ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
Open Access
- 1 May 2005
- journal article
- guideline
- Published by Elsevier BV in Annals Of Oncology
- Vol. 16 (suppl_1), i77-i79
- https://doi.org/10.1093/annonc/mdi805
Abstract
1Invited author, University Hospital Herlev, Dept. of Oncology 54B1, DK-2730 Herlev, Denmark; 2Invited author, Clinique de Genolier, 1 route du Muids, CH-1245 Genolier, Switzerland; 3Invited author, Medical Oncology Division, Silvestrini Hospital, 06080 S.Sisto, Perugia, Italy; 4Assigned task force member, University Hospital of Kuopio, POB 1777, FIN-70211 Kuopio, FinlandKeywords
This publication has 3 references indexed in Scilit:
- Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.Cancer Investigation, 2004
- Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 1999
- Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus ConferenceAnnals Of Oncology, 1998